With 2.14 million shares changed hands, the volume of the stock remained lighter than its average volume of 49.27 million shares. During the session, the Health Information Services company that operates in wider Healthcare sector, reached to the highest price of $0.2966 whereas the lowest price it dropped to was $0.26. The 52-week range on FOXO shows that it touched its highest point at $1.30 and its lowest point at $0.13 during that stretch. Beta for the stock currently stands at 3.50.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of FOXO was down-trending over the past week, with a drop of -4.37%, but this was down by -42.24% over a month. Three-month performance surged to 65.90% while six-month performance rose 12.07%. The stock lost -1.54% in the past year, while it has lost -1.48% so far this year.
Float and Shares Shorts:
At present, 19.00 million FOXO shares are outstanding with a float of 16.71 million shares on hand for trading. On 2024-10-31, short shares totaled 53708.0, which was 38.99999999999999 higher than short shares on 1727654400. In addition to Mr. Mark Brian White as the firm’s Interim CEO & Director, Mr. Martin Christopher Ward FCA serves as its Interim Chief Financial Officer.
Institutional Ownership:
Through their ownership of 0.02259 of FOXO’s outstanding shares, institutional investors have minority control over the company.
An Overview of Recent Financials:
Understanding a company as a customer does not mean you will understand it as an investor. The wise investor uses quantitative research to analyze metrics such as revenue, net income, and earnings. In its fiscal quarter reported on 2024-06-30, FOXO reported revenue of $1196000.0 and operating income of -$1121000.0. The EBITDA in the recently reported quarter was -$831000.0 and diluted EPS was -$0.15.
Analysts Ratings:
In the same way, a target price assigned to a stock can also reveal much about its potential.
